|  Help  |  About  |  Contact Us

Publication : Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.

First Author  Wei H Year  2017
Journal  J Am Heart Assoc Volume  6
Issue  1 PubMed ID  28119285
Mgi Jnum  J:273937 Mgi Id  MGI:6282948
Doi  10.1161/JAHA.116.004968 Citation  Wei H, et al. (2017) Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor beta Signaling. J Am Heart Assoc 6(1)
abstractText  BACKGROUND: Marfan syndrome (MFS) is caused by mutations in the gene encoding fibrillin-1 (FBN1); however, the mechanisms through which fibrillin-1 deficiency causes MFS-associated aortopathy are uncertain. Recently, attention was focused on the hypothesis that MFS-associated aortopathy is caused by increased transforming growth factor-beta (TGF-beta) signaling in aortic medial smooth muscle cells (SMC). However, there are many reasons to doubt that TGF-beta signaling drives MFS-associated aortopathy. We used a mouse model to test whether SMC TGF-beta signaling is perturbed by a fibrillin-1 variant that causes MFS and whether blockade of SMC TGF-beta signaling prevents MFS-associated aortopathy. METHODS AND RESULTS: MFS mice (Fbn1(C1039G/+) genotype) were genetically modified to allow postnatal SMC-specific deletion of the type II TGF-beta receptor (TBRII; essential for physiologic TGF-beta signaling). In young MFS mice with and without superimposed deletion of SMC-TBRII, we measured aortic dimensions, histopathology, activation of aortic SMC TGF-beta signaling pathways, and changes in aortic SMC gene expression. Young Fbn1(C1039G/+) mice had ascending aortic dilation and significant disruption of aortic medial architecture. Both aortic dilation and disrupted medial architecture were exacerbated by superimposed deletion of TBRII. TGF-beta signaling was unaltered in aortic SMC of young MFS mice; however, SMC-specific deletion of TBRII in Fbn1(C1039G/+) mice significantly decreased activation of SMC TGF-beta signaling pathways. CONCLUSIONS: In young Fbn1(C1039G/+) mice, aortopathy develops in the absence of detectable alterations in SMC TGF-beta signaling. Loss of physiologic SMC TGF-beta signaling exacerbates MFS-associated aortopathy. Our data support a protective role for SMC TGF-beta signaling during early development of MFS-associated aortopathy.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

9 Bio Entities

Trail: Publication

0 Expression